Sunshine Biopharma (SBFM) Inventory Average (2019 - 2026)

Sunshine Biopharma has reported Inventory Average for 8 years, with the latest figure at $13.3 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 15.15% year-over-year to $13.3 million; the trailing twelve-month figure through Mar 2026 stood at $13.3 million (up 15.15% YoY), and the FY2025 full-year result was $12.4 million, up 45.48% from the prior year.
• Inventory Average for Q1 2026 stood at $13.3 million, down from $13.8 million in the prior quarter.
• The five-year high for Inventory Average was $13.8 million in Q4 2025, with the low at $143573.0 in Q1 2022.
• Historically, Inventory Average has averaged $7.0 million across 5 years, with a median of $6.7 million in 2024.
• Annual changes were most pronounced in 2023 — Inventory Average surged 2337.76% — and 2026, when it grew 15.15%.
• Sunshine Biopharma's Inventory Average stood at $1.8 million in 2022, then jumped by 188.01% to $5.1 million in 2023, then soared by 105.81% to $10.5 million in 2024, then jumped by 30.51% to $13.8 million in 2025, then decreased by 3.25% to $13.3 million in 2026.
• The last three Inventory Average figures came in at $13.3 million (Q1 2026), $13.8 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.